drug · protein
patient view →EYLEA HD
Marketedupdated 2mo agoby $REGN REGENERON PHARMACEUTICALS, INC.🔗 ChEMBL
Approvedannual revenue · 2024–2024peak $9.4B
community read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with 16 approved and 39 investigational indications.
indications
investigational
Diabetic Macular Edema
targets
Placenta growth factorVascular endothelial growth factor A, long form
all catalysts(5)
approval · 5
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that